Shield Laws Upend Abortion Bans

For the first time since state bans took effect, more residents in total-ban states got abortion pills by mail than traveled for procedures, according to new estimates.

Story Highlights

Researchers estimate 90,460 telehealth pill provisions to residents of 13 total-ban states in 2025, versus 64,590 who traveled for abortions.
Coverage links the rise to “shield laws” in supportive states that protect out-of-state telehealth providers who mail medications.
The dataset tracks clinician-provided care and excludes community networks and nonprescription online sellers, limiting a full count.
Travel for abortions fell from 2023 to 2025 as telehealth options increased nationally.

What the new numbers show about access in ban states

A research letter summarized by The American Journal of Managed Care reports that, in 2025, residents in the 13 states with total abortion bans received an estimated 90,460 telehealth provisions from United States clinicians, compared with 64,590 abortions after traveling out of state. Public television coverage said this marked the first year when telehealth outpaced travel for these residents. The Hill reported similar figures, reinforcing the crossover pattern found in the underlying provider-based estimates.

Guttmacher’s Monthly Abortion Provision Study underpins the comparison and counts abortions provided by clinicians, including those delivered by telehealth. The same data show that, nationwide, abortion access has shifted since the Supreme Court’s Dobbs decision. Interstate travel climbed in 2023, then eased by 2025, while telehealth grew as a channel for people in states with bans or tight limits. These estimates frame the trend but do not capture every path people use to obtain pills.

How state policies and “shield laws” shape the trend

PBS reported that eight states adopted “shield laws” that protect clinicians who prescribe and mail abortion pills to patients in states with bans, insulating providers from many out-of-state legal risks. Analysts link these laws to the rise in telehealth care for residents in total-ban states, who can now consult a clinician across state lines and receive medications by mail. This policy split—ban states restricting access and shield-law states protecting prescribers—has redrawn the map of how care is delivered.

Guttmacher’s broader reporting describes the same dynamic: more people sought telehealth in 2025 as travel dipped from the prior year. That shift does not prove that telehealth replaced travel one-for-one. Different patients face different needs, costs, and time pressures. But the legal safe harbor for clinicians in some states, paired with strict bans in others, helps explain why the mail route grew while long trips to clinics fell for many residents of ban states.

What the estimates include—and what they miss

The study tracks clinician-reported care, which is a defined and auditable slice of the system, but it does not measure everything. The authors caution that counting mailed pill provisions is not the same as confirming completed abortions. Some patients may not take the pills or may receive more than one shipment. The dataset also excludes community networks and websites that sell pills without prescriptions, leaving gaps in any complete count. Travel may also be undercounted if clinics recorded a different residence.

1,129,020 abortions in America in 2025, up from 1,108,810 in 2024.

Mail-order pills are driving the rise, now 28% of all abortions.

No doctor visit. No ultrasound. No screening for ectopic pregnancy.

Tell Congress to end mail-order abortion:https://t.co/4GgWbN4bAk pic.twitter.com/f8Y7nomnnN

— Foundation for Life Northwest Ohio (@FFL_NWO) October 30, 2026

Other reports note that medication abortions sent by mail rose as a share of all abortions after Dobbs, but that national trend should not be confused with the narrower finding about residents in total-ban states. The comparison here is specific: it weighs telehealth provisions versus out-of-state travel among people who live in 13 states with total bans in 2025. The national picture, and states with partial limits, follow related but not identical patterns.

Why this matters for both parties—and for trust in government

These numbers reveal a core reality: rules in one state now trigger workarounds in another. For many readers, left and right, that looks like a system that does not resolve hard problems but shifts them across borders. Supporters of bans see laws being bypassed through mail. Supporters of access see bans blocking in-person care and forcing remote options. Both sides can agree this patchwork fuels confusion, legal risk, and unequal access that undercuts faith in government’s ability to set clear, fair policy.

What to watch next as policy and courts keep moving

Future counts will hinge on court rulings and new laws. Changes to shield-law protections, postal enforcement, or state prosecution strategies could reshape telehealth supply lines. If more clinics tighten reporting or states improve data on patient residence, travel figures could shift as well. Until then, the best-supported takeaway is narrow but important: in 2025, for residents of 13 total-ban states, clinician-reported telehealth pill provisions exceeded documented out-of-state procedures.